
RC Tritec supplies high-quality tritium-labeled compounds for pharmaceutical and biochemical research, supporting radioligand binding studies, target engagement assays and drug discovery programs across key therapeutic target classes. Researchers investigating GPCR pharmacology, ligand-gated ion channels, broader ion channel receptors, nuclear receptors and enzyme targets can rely on RC Tritec’s expertise in tritium chemistry, catalog radioligands and custom labeling to obtain radiochemicals designed for reliable biological activity, reproducible results and confident interpretation of biochemical processes.

from CHF 1'800.–
In stock
from CHF 3'900.–
In stock
from CHF 1'100.–
In stock
from CHF 2'500.–
In stock
from CHF 4'100.–
In stock
from CHF 2'100.–
In stock
from CHF 3'000.–
In stock
from CHF 1'000.–
In stock
from CHF 1'100.–
In stock
from CHF 5'000.–
In stock
from CHF 2'400.–
In stock
from CHF 3'400.–
In stock
from CHF 2'600.–
In stock
from CHF 4'000.–
In stock
from CHF 2'400.–
In stock
from CHF 1'000.–
In stock
from CHF 2'200.–
In stock
from CHF 4'200.–
In stock
from CHF 1'300.–
In stock
from CHF 3'100.–
In stock
from CHF 1'900.–
In stock
from CHF 1'100.–
In stock
from CHF 1'200.–
In stock
from CHF 1'000.–
In stock
from CHF 4'100.–
In stockWe are here to help. Upon request, we will gladly add your custom tritium-labeled compound to our catalog to ensure a continuous and reliable supply of your radioligand.

Tritium-labelled compounds are useful in the pre-clinical stage of drug development as it allows for the specific distribution of the compound throughout the cell and the whole body of an organism. Additionally, metabolites of the used compound can also be tracked in an assay which is called metabolite identification (Met-ID).